相关实验视频

Updated: Sep 14, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

在印度比较药物耐药结核病治疗短期疗程的成本效益

Malaisamy Muniyandi¹, Balaji Ramraj², Sathishkumar Vadamalai¹

¹Department of Health Economics, ICMR-National Institute for Research in Tuberculosis, Chennai, India.

International journal of technology assessment in health care

|July 21, 2025

概括

较短的耐药结核病 (DR-TB) 疗法,特别是mPaL2和mPaL1,比标准治疗更具成本效益. 基于贝达基林的治疗方法提供了更高的有效性和减少了卫生系统的负担.

科学领域:

药物经济学药物经济学
传染病管理传染病管理
公共卫生公共卫生

背景情况:

耐多药结核病 (DR-TB) 的治疗是漫长而昂贵的.
目前正在研究短期治疗方案,以改善结果和患者的坚持.
这项研究将七种短期DR-TB治疗方案的成本效益与标准护理进行比较.

研究的目的:

为了确定在印度最具成本效益的短疗程治疗DR-TB治疗方案.
为了比较新方案的经济影响与当前的护理标准.
评估贝达基林含有的疗法在DR-TB管理中的价值.

主要方法:

从卫生系统的角度使用决策树模型.
成本数据 (前期调查,治疗方案,ADR管理,住院护理) 和效果数据 (临床结果,ADR) 来自已公布的来源.
估计了增量成本效益比率 (ICER) 和质量调整寿命年 (QALY),并进行了灵敏度分析.

主要成果:

与标准护理相比,所有评估的短期治疗方案都显示出100%的成本效益.
确定mPaL2疗法是占主导地位的策略,而mPaL1则表现出延长的主导地位.
药物成本,特别是Bedaquiline,显著影响这些方案的成本效益.

结论:

基于贝达基林的疗法代表了对DR-TB的更有效和更短的治疗选择.
这些方案对医疗保健系统的负担较小.
这些发现支持实施更短的,含贝达基林的疗法,以改善DR-TB管理.

关键词:

这就是Beat Beat.BPaL BPaL 在线阅读在 BPaLC 中.在 BPaLM 找 BPaLM 这就是DR-TB.这就是为什么TBTBTBTB 经济效益性经济效益性 mBPaL mBPaL 在线阅读较短的疗程更短的疗程

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...